203 related articles for article (PubMed ID: 25008929)
1. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease.
Taylor KG; Woods TA; Winkler CW; Carmody AB; Peterson KE
J Virol; 2014 Oct; 88(19):11070-9. PubMed ID: 25008929
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes have a role in protection, but not in pathogenesis, during La Crosse Virus infection in mice.
Winkler CW; Myers LM; Woods TA; Carmody AB; Taylor KG; Peterson KE
J Neuroinflammation; 2017 Mar; 14(1):62. PubMed ID: 28340587
[TBL] [Abstract][Full Text] [Related]
3. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
[TBL] [Abstract][Full Text] [Related]
4. Age influences susceptibility of brain capillary endothelial cells to La Crosse virus infection and cell death.
Basu R; Nair V; Winkler CW; Woods TA; Fraser IDC; Peterson KE
J Neuroinflammation; 2021 Jun; 18(1):125. PubMed ID: 34082753
[TBL] [Abstract][Full Text] [Related]
5. Innate immune response to La Crosse virus infection.
Taylor KG; Peterson KE
J Neurovirol; 2014 Apr; 20(2):150-6. PubMed ID: 23846288
[TBL] [Abstract][Full Text] [Related]
6. The CARD9-Associated C-Type Lectin, Mincle, Recognizes La Crosse Virus (LACV) but Plays a Limited Role in Early Antiviral Responses against LACV.
Monteiro JT; Schön K; Ebbecke T; Goethe R; Ruland J; Baumgärtner W; Becker SC; Lepenies B
Viruses; 2019 Mar; 11(3):. PubMed ID: 30917612
[TBL] [Abstract][Full Text] [Related]
7. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
Schuh T; Schultz J; Moelling K; Pavlovic J
Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
[TBL] [Abstract][Full Text] [Related]
8. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.
Blakqori G; Delhaye S; Habjan M; Blair CD; Sánchez-Vargas I; Olson KE; Attarzadeh-Yazdi G; Fragkoudis R; Kohl A; Kalinke U; Weiss S; Michiels T; Staeheli P; Weber F
J Virol; 2007 May; 81(10):4991-9. PubMed ID: 17344298
[TBL] [Abstract][Full Text] [Related]
9. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
[TBL] [Abstract][Full Text] [Related]
10. Interferon-Regulatory Factor 5-Dependent Signaling Restricts Orthobunyavirus Dissemination to the Central Nervous System.
Proenca-Modena JL; Hyde JL; Sesti-Costa R; Lucas T; Pinto AK; Richner JM; Gorman MJ; Lazear HM; Diamond MS
J Virol; 2016 Jan; 90(1):189-205. PubMed ID: 26468541
[TBL] [Abstract][Full Text] [Related]
11. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of infectivity of insect cell-derived La Crosse Virus by human serum.
Cruz MA; Parks GD
Virus Res; 2021 Jan; 292():198228. PubMed ID: 33188797
[TBL] [Abstract][Full Text] [Related]
13. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice.
Kallfass C; Ackerman A; Lienenklaus S; Weiss S; Heimrich B; Staeheli P
J Virol; 2012 Oct; 86(20):11223-30. PubMed ID: 22875966
[TBL] [Abstract][Full Text] [Related]
14. Neuronal maturation reduces the type I IFN response to orthobunyavirus infection and leads to increased apoptosis of human neurons.
Winkler CW; Woods TA; Groveman BR; Carmody AB; Speranza EE; Martens CA; Best SM; Haigh CL; Peterson KE
J Neuroinflammation; 2019 Nov; 16(1):229. PubMed ID: 31739796
[TBL] [Abstract][Full Text] [Related]
15. Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.
Dawes BE; Gao J; Atkins C; Nelson JT; Johnson K; Wu P; Freiberg AN
J Neuroinflammation; 2018 Nov; 15(1):315. PubMed ID: 30442185
[TBL] [Abstract][Full Text] [Related]
16. Effects of La Crosse virus infection on pregnant domestic rabbits and mongolian gerbils.
Osorio JE; Schoepp RJ; Yuill TM
Am J Trop Med Hyg; 1996 Oct; 55(4):384-90. PubMed ID: 8916793
[TBL] [Abstract][Full Text] [Related]
17. La Crosse Virus Disease in the United States, 2003-2019.
Vahey GM; Lindsey NP; Staples JE; Hills SL
Am J Trop Med Hyg; 2021 Jul; 105(3):807-812. PubMed ID: 34280142
[TBL] [Abstract][Full Text] [Related]
18. Identification of age-specific gene regulators of La Crosse virus neuroinvasion and pathogenesis.
Basu R; Ganesan S; Winkler CW; Anzick SL; Martens C; Peterson KE; Fraser IDC
Nat Commun; 2023 May; 14(1):2836. PubMed ID: 37202395
[TBL] [Abstract][Full Text] [Related]
19. Differences in neuroinvasion and protective innate immune pathways between encephalitic California Serogroup orthobunyaviruses.
Evans AB; Winkler CW; Peterson KE
PLoS Pathog; 2022 Mar; 18(3):e1010384. PubMed ID: 35245345
[TBL] [Abstract][Full Text] [Related]
20. La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro.
Cruz MA; Parks GD
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
